Mutations in breast cancer gene 1 (<i>BRCA1</i>) and breast cancer gene 2 (<i>BRCA2</i>) have been associated with male breast cancer (MBC), as well as prostate cancer (PCa). This evidence concerns the gene BRCA2 and male breast carcinoma.